BMT | CBT | PBSCT | |
Patients (n) (male/female) | 7 (4/3) | 12 (6/6) | 5 (3/2) |
Age (years) | 50.4 (36–63) | 60.5 (44–69) | 54.0 (47–67) |
Body weight (kg) | 64.0 (45.7–84.1) | 50.7 (32.9–68.8) | 58.4 (44.6–77.8) |
ALT (U/L) | 26.7 (15–44) | 40.2 (15–77) | 43.0 (11–110) |
AST (U/L) | 27.7 (14–55) | 44.5 (19–116) | 40.6 (9–127) |
TB (mg/dL) | 0.96 (0.4–2.7) | 0.95 (0.5–2.0) | 0.80 (0.2–2.2) |
CLcre (mL/min) | 134.1 (74.8–220.9) | 96.0 (37.0–143.8) | 102.0 (60.7–131.2) |
Analysis point | 14 | 28 | 12 |
Age, body weight, ALT, AST, TB and CLcre are expressed as average values at transplantation date with the range in brackets. There are no significant differences.
ALT, alanine transaminase; AST, aspartate transaminase; BMT, bone marrow transplantation; CBT, cord blood transplantation; CLcre, creatinine clearance; PBSCT, peripheral blood stem cell transplantation; TB, total bilirubin.